Effect of siRNA interference targeting BMPR-Ⅱ gene on cell proliferation and invasion ability of human hepatoma HepG2 cells
CAI Sheng,XU Guan-jun,LI Ling,JIANG Wei-min,WU Jian-bing
DOI: https://doi.org/10.3969/j.issn.1007-3969.2012.02.005
2012-01-01
Abstract:Background and purpose:Primary hepatocellular carcinoma is one of the most common malignant tumors in our country.Recent studies showed that bone morphogenetic proteins(BMPs) signaling pathways play a key role in the development of tumors.This study aimed to investigate the effect of small interfering RNA(siRNA) on the inhibiting of bone morphogenetic protein receptor(BMPR-Ⅱ),and to observe its effect on the proliferation and invasion of human hepatoma HepG2 cells after BMPR-Ⅱ silencing.Methods:Three pairs of specific siRNA targeting BMPR-Ⅱ were designed and synthesized,and then transiently transfected into HepG2 cells via cathodolyte liposome transfection method.In vitro cultured HepG2 cells were divided into a normal control group,a blank control group,a negative control group and 3 transfected with siRNA-BMPR-Ⅱ-a,siRNA-BMPR-Ⅱ-b,siRNA-BMPR-Ⅱ-c groups.RT-PCR and Western blot were used to detect BMPR-Ⅱ expression at mRNA and protein levels,and the proliferation and invasion ability of HepG2 cells after transfection were assessed by MTT assay and Transwell invasion assay respectively.Results:Forty-eight hours after the 3 pairs of specific siRNA-BMPR-Ⅱ were transfected into HepG2 cells,RT-PCR and Western blot results showed that the expression of BMPR-Ⅱ mRNA and protein were significantly inhibited compared with those in the other 3 groups,with siRNA-BMPR-Ⅱ-a having the highest inhibitory rate(0.70±0.06,0.45±0.10,P<0.05).MTT assay and Transwell invasion assay demonstrated the growth and the number of HepG2 cells in siRNA-BMPR-Ⅱ-a group was significantly lower(48.27%±0.76%,25.20±1.60,P<0.05) than in normal control group(82.64%±0.67%,60.40±1.39) and negative control group(81.21%±0.80%,59.50±1.85) at 48 h after transfection.Conclusion:siRNA interference-mediated BMPR-Ⅱ gene silencing can inhibit the proliferation and invasion ability of human HepG2 cells,and BMPR-Ⅱ gene may be used as a new promising target of antineoplastic therapy in hepatocellular carcinoma.